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Reciprocal interaction between oral ectodermal epithelial cells and mesenchymal stem cells (MSCs)-derived from the 
cranial neural crest starts the teeth development. The role of dental MSCs continues throughout life. The dental MSCs do 
not only play a role in tooth development but also in tooth homeostasis and repair. There are many kinds of dental MSCs, 
such as dental pulp stem cell (DPSC), stem cell from apical papilla (SCAP), stem cell from exfoliated deciduous teeth (SHED), 
periodontal ligament stem cell (PDLSC) and stem cell from dental follicle (DFSC). Aligned with the proposed criteria by the 
International Society for Cellular Therapy (ISCT), dental MSCs are adherent cells and like other MSCs, dental tissue MSCs are 
capable of giving rise to cell lineages such as osteo/odontogenic, adipogenic, and neurogenic. Various surface antigens of 
dental MSCs were reported, however, mostly typical antigens suggested by ISCT were fulfilled. Surface antigens from each 
dental MSCs (DPSC, SCAP, SHED, PDLSC and DFSC) are being described in the current report.  
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Introduction
Teeth are complex organs which exhibit limited repair in 
response to damage. It has two separate specialized hard 
tissues which are enamel and dentin. Enamel is formed from 
oral ectodermal epithelial cells which give rise to enamel-
forming ameloblasts. On the other hand, mesenchymal stem 
cells (MSCs) will form all other differentiated cells such as 
odontoblasts, pulp and periodontal ligament (PDL).1,2 The 
teeth will not stop to develop and will continue to develop 
postnatal, forming a tooth that is functional.
 It has been proposed that the tooth might contain stem 
cells by an observation that teeth could do a repair process 
in which new odontoblasts are formed. The presence of 
different types of MSCs have been suggested depending 
on the site they have been harvested.3 Dental pulp stem 
cell (DPSC), one of the examples of MSCs in teeth, is 
considered to share the same properties with MSCs and 
have several therapeutic potentials.2 Thus repair, restoration 
and replacement of teeth are possible with the usage of stem 
cells. Significantly non-dental used such as stem cell-based 
therapies for major life-threatening disease may also be 
possible.1
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 This review will outline the role of stem cells in tooth 
development, the importance of its biological properties, 
various types of dental stem cell and the criteria of dental 
tissue-derived MSCs.
Stem cells in tooth development
Teeth first develop through the mutual interaction between 
oral ectodermal epithelial cells and MSCs derived from the 
cranial neural crest (CNC). First, an enamel organ will be 
formed, followed by papilla and dental follicle. The MSCs 
form the most of the soft and hard tissues around and in the 
tooth, such as dental pulp, dentin, alveolar bone and PDL.3,4 
The enamel is formed by ameloblasts derived from the oral 
epithelium, while the dentin is synthesized by odontoblasts 
which derived from dental papilla and MSCs.5
 The role of dental MSCs continues throughout life. The 
dental MSCs do not only play a role in tooth development 
but also in tooth homeostasis and repair.6 The cells will 
generate odontoblasts to repair the damaged dentin. Dental 
MSCs in the PDL will be involved in repairing the PDL. 
However, enamel can’t be naturally repaired or replaced 
because the epithelial-derived ameloblasts are lost when the 
teeth erupt.
Origin of dental stem cells
MSCs are in charge of forming most of the soft and hard 
tissues in and around the tooth while the epithelium is in 
charge of mainly producing the ameloblasts. The dental 
MSCs are derived from two different origins which are 
the CNC and non-CNC mesoderm. The neural crest is 
a transitory population of cells that emerge from lateral 
ridges of neural plate during early embryogenesis and 
then differentiate into neurons, glia, melanocytes and 
mesenchymal cells.4 The CNC-derived mesenchyme will 
migrate, proliferate and differentiate into more specialized 
cells which are odontoblasts, cementoblasts, fibroblasts, 
osteoblasts and chondroblasts.7 Studies showed that CNC-
derived ectomesenchyme along with dental epithelium 
supported the tooth formation. It is proposed that CNC-
derived mesenchyme are odontogenic, either they possessed 
instructive odontogenic with the potential to initiate 
tooth development or possessed the ability to respond to 
odontogenic signals such as Fibroblast Growth Factor 8 
(FGF8) to support the tooth formation.8 Besides that, the 
signaling of mothers against Drosophila melanogaster 4 
(Smad4)-mediated Bone Morphogenic Proteins (BMP) in 
the CNC-derived mesenchyme is required so that the tooth 
development could progress into the bud stage.9 Thus, it 
could be said that CNC-derived mesenchyme holds a crucial 
role in tooth development. 
 During the early bud stage, the condensed dental 
mesenchyme is mainly populated by CNC-derived cells.10 
As the tooth develop and enter the late bud stage, a significant 
number of CNC-derived cells with some non-CNC cells are 
present in the condensed dental mesenchyme. When the 
tooth bud continues to proliferate and enter the cap stage, 
the amount of non-CNC cells increase. Therefore, as the 
tooth develops, especially during the cap and bell stages, 
the blood vessels invade the dental papilla, a number of non-
CNC cells increases in the dental mesenchyme.7,11
 A transplantation method using the LacZ 
(β-galactosidase) reporter gene transgenic and wild-type 
mice is used to understand the origin and the migration 
mechanism of non-CNC-derived cells.7 Animals with the 
reporter gene such as lacZ are suitable for cell lineage 
analysis and investigation of migration, proliferation 
and differentiation during development and regeneration 
processes.7,10 The result showed that the circulating cells 
invade the developing dental pulp via the endothelium of 
the blood vessel, reside in the dental pulp, and become the 
non-CDC-derived cell. Thus, the study suggested that these 
circulating progenitor cells could be the origin of non-CNC-
derived cells in tooth germ.7
Dental stem cells
Adult Stem Cells (ASCs) could be found in our body tissues, 
such as dental tissues. Like other MSCs, dental tissue MSCs 
are capable of giving rise to cell lineages such as osteo/
odontogenic, adipogenic and neurogenic.12 Dental stem 
cells can be classified into two categories based on their 
differentiation potentials toward the dentin or periodontium 
tissues. DPSC, stem cell from apical papilla (SCAP) and 
stem cells from exfoliated deciduous teeth (SHED) are 
classified in the first category which is associated with the 
dental pulp complex formation. The second group, includes 
PDL stem cell (PDLSC) and dental follicle stem cell 
(DFSC), is related to the formation of the periodontium.13
DPSC
DPSC was first isolated and characterized from normal 
human impacted third molars. The pulp was gently separated 
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from the crown and root, then digested in a solution and 
processed to obtain single-cell suspensions, After that it was 
seeded to form colonies.14 A study reported that DPSC has a 
higher proliferation rate, a greater clonogenic potential and 
a higher number of stem/progenitor cells in the population 
and may have increased mineralization potential compared 
to BMSC.15 
 There are four commonly used stem cell identification 
techniques such as fluorescent antibody cell sorting. In 
this technique, stem cells can be identified and isolated 
from mixed cell populations by staining the cells with 
specific antibody markers and using a flow cytometer. 
Other techniques are immunomagnetic bead selection, 
immunohistochemical staining and physiological and 
histological criteria, including phenotype, proliferation, 
chemotaxis, mineralizing activity and differentiation.16
 Several immunohistochemical studies were performed 
to characterize the progeny of the DPSC populations, by 
using a panel of antibodies specific. DPSC showed positivity 
markers cluster of differentiation (CD)73 and C90, CD105, 
CD146, stromal precursor antigen (STRO)-1, CD106, CD29, 
CD49, CD51, CD61, CD166, Aldehyde dehydrogenase 
(ALDH)1, CD44, CD9, CD10 CD13, CD59, mesenchymal 
stem cell antigen -1 (MSCA-1), CD81, CD24, CD271/
nerve growth factor receptor (NGFR), Nestin, doublecortin 
(DCX), βΙΙΙ-tubulin, neuronal nuclei (NeuN), glial fibrillary 
acidic protein (GFAP), S-100, A2B5, 2',3'-cyclic nucleotide 
3'-phosphodiesterase (CNPase), musashi-1, p75, snail 
family transcriptional repressor 1 (snail-1), snail-2, slug, sex 
determining regio Y-box 9 (Sox-9), nanog, organic cation/
carnitine transporter 3/4 (Oct3/4), stage specific embryonic 
antigens -1 (SSEA-1), SSEA-3, SSEA-4, SSEA-5, notch 
homolog-1 (Notch-1), Notch-2, Notch-3. DPSC was 
negative for CD14, CD19, CD34, CD45, CD117, CD133 
and human leukocyte antigen - antigen D related (HLA-
DR).14,17,18
 Stem cells from the pulp are capable of differentiating 
in vitro and in vivo into osteoblast, which can be used 
directly for dental therapy. DPSC can also differentiate 
into adipocyte, chondrocyte, hepatocyte, dentin-pulp like, 
complex, neuron, cornea epithelial cell, melanoma cell 
and insulin-secreting beta cells. Because of this capability, 
DPSC can become an alternative for non-invasive source to 
be used for future regenerative therapies.14,19,20
SCAP
SCAP can be found in the developing tissue-apical papilla 
of immature permanent teeth. SCAP is one of the MSCs 
that has an important role in wound healing of incomplete 
tooth development.21 It is believed to be the main source of 
undifferentiated cells in the process of root development.22 
Cells in apical papilla proliferated two to three fold greater 
than those in pulp in organ cultures.23
 SCAP has faster cell division as well as higher 
population doubling level and ability to create dentin in 
vivo. Furthermore, the population of stem cells derived from 
this tissue is positive for specific markers of MSCs, such 
as CD146,21,24 CD44, CD73, CD90, CD105 and CD106.22 
SCAP also showed negative markers of hematopoietic stem 
cells, mature blood cells such as CD18, CD34, CD45 and 
HLA-DR.21 Apical papilla is distinctive to a pulp regarding 
containing less cellular and vascular components than 
those in a pulp.23 Soft tissue from the outer apical papilla 
has shown positive for STRO-121,23,24 and CD24-surface 
markers of SCAP. These markers will be lost during cell 
differentiation and generate dentin.21
 SCAP has the potential to differentiate into bone and 
dentin as the bone marrow-derived MSCs (BM-MSCs).22,23 
SCAP is capable of differentiating into odontoblastic 
lineages in vitro and form ectopic pulp-dentine like 
tissue complexes when transplanted subcutaneously into 
immunocompromised mice in vivo.24
SHED
The presence of SHED was first identified from normal 
exfoliated human deciduous incisors 7 to 8-year-old children 
as a population of heterogeneous cells that represent more 
immature stem cell population and capable of extensive 
proliferation and multipotential differentiation.25 SHED 
has several advantages over other stem cells derived from 
teeth because SHED is reported to have higher proliferation 
rate and higher population doublings, multilineage 
differentiation capacity, no risk for developing immune 
reactions or rejection following transplantation exist, and 
no immunosuppressive therapy is needed.
 Apparently, SHED represents a population of 
multipotent stem cells that perhaps more immature 
than previously examined postnatal stromal stem cell 
populations. SHED can form sphere-like cell cluster and 
obtained naturally or non-invasively from almost every 
human being resulting in minimal or no pain or discomfort. 
During long-term cultivation, it does not show any signs of 
degeneration or spontaneous differentiation.25,26,27
 Several studies with flow cytometry analysis which 
used a panel of cell surface markers revealed expression 
pattern for a variety of markers for SHED. A study showed 
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that ex vivo-expanded SHED was found to express the cell 
surface molecules STRO-1 and CD146.25 Others studies 
showed that SHED was also expressed positivity for CD90, 
CD73, CD105, CD44, CD13, Nestin, DCX, βΙΙΙ-tubulin, 
NeuN, GFAP, S-100, A2B5, CNPase Nanog, Oct3/4 and 
SSEAs (-3, -4). However, other studies described that 
SHED is negative for CD14, CD45 and CD34 while other 
studies showed that SHED is negative for CD11b, CD19 
and CD43.18,25,28,29
 Several studies described that SHED could 
differentiate in vitro and in vivo into adipocytes which can be 
used to treat many spine and orthopedic conditions, Crohn’s 
disease and cardiovascular diseases. It may also be useful 
in plastic surgery. Besides that, SHED can differentiate 
into osteoblasts, hepatocytes, neural cells, chondrocytes, 
myocytes, skin cells, liver cells and odontoblasts.25,30,31
PDLSC
The periodontium is a soft connective tissue surrounding 
and supporting the tooth, including cementum, PDL and 
alveolar bone that function as an integrated unit. It is 
functionally important for tooth support. Another important 
role of the PDL is to regulate alveolar bone volume and to 
serve as a cell reservoir for tissue homeostasis, contributes 
to tooth nutrition and regeneration, and during mastication, 
PDL acts as a sensory organ for the proper positioning of 
the jaws.32,33
 The presence of multipotent postnatal PDLSC was 
first described from normal impacted third molar collected 
from 16 individuals aged 19-29 years. PDL was gently 
separated from the surface of the root, processed into single-
cell suspensions, and expanded in vitro, providing a unique 
reservoir of stem cells from an accessible tissue resource. 
Immunohistochemical staining, RT-PCR, northern and 
western blot analysis were used to identify putative stem-
cell markers. The human PDLSC can also be isolated from 
human periodontium using a minimally invasive periodontal 
access flap surgery in healthy donors.32,34
 Flow cytometry revealed that the isolated cells were 
positive for STRO-1 and CD146, CD44, CD90, CD105, 
CD166, Oct-3/4, Sox2, nanog and nestin antibodies. 
However it lacks the expression of CD45, CD34 and CD14 
or CD11b, CD79a, or CD19 and HLA class II.29,32,35
 PDLSC has demonstrated the ability to differentiate 
into periodontal tissues such as the cementoblast-like cell, 
PDL tissue repair and alveolar bone in experimental animal 
models. It can also differentiate into osteogenic, adipogenic, 
chondrogenic and typical neuronal morphology comparable 
with previously characterized BMSC. Therefore, PDLSC 
can potentially be isolated and expanded in vitro as an 
excellent cellular source for PDL regenerative therapies, 
with minimal discomfort due to invasive procedures 
commonly performed.32,34,36,37
DFSC
The human dental follicle is a fibrous ectomesenchymal 
tissue sac and part of the tooth germ. It surrounds the 
whole enamel organ and limits the dental papilla at early 
stages of tooth development. The dental follicle regulates 
the osteoclastogenesis and osteogenesis needed for tooth 
eruption and tooth root development of the periodontium 
that consists of three different types of tissues: the alveolar 
bone, the PDL and cementum.38,39
 Under specific culture conditions, DFSC can 
differentiate into multiple lineages cell types such as 
osteoblasts, cementoblasts, adipocytes and neuron-like 
cells.39 DFSC possesses strong osteogenic capability to 
differentiate toward the osteoblast lineage.40
 Precursor cells isolated from dental follicle expressed 
nestin,38 STRO-1, Oct3/4, Sox-2, Nanog and Notch, and are 
negative for markers of hematopoietic lineage CD34 and 
CD117, and positive for CD44, CD29, CD90, and CD105, 
indicating that those cells are mesenchymal cells. DFSC can 
adhere to plastic and form colonies.39
MSCs in accordance to the International 
Society for Cellular Therapy (ISCT)
Historically, MSCs were first isolated and expanded from 
marrow aspirates of the iliac crest.41 It has more recently 
been demonstrated that MSCs can be isolated from other 
tissues, including fat, extracted teeth, periosteum and 
alveolar bone.25,32,42-45 Other studies have demonstrated that 
osteogenic cells can be isolated from alveolar bone tissues 
by various methodologies.43,45-48 Yet, only one of these 
has defined the cell populations as MSCs, according to 
ISCT, and none has described a standardized, predictable 
methodology for tissue harvest with a large population of 
patients.49
 DMSCs are nonhematopoietic stromal cells that 
have important characteristic, in which they are capable of 
differentiating, proliferating and regenerating mesenchymal 
tissues such as bone, cartilage, marrow stroma, connective 
tissue, muscle, tendon, adipose and ligament.19,20. MSCs have 
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the potential to differentiate into many different specialized 
cells in the body and serve to repair or regenerate the tissues 
depending on culture conditions and non-mesoderm-type 
cells. In addition, MSCs are also hypoimmunogenic and 
evade allorejection. MSCs express telomerase and can 
maintain it longer than other somatic cells. Not only that, 
they have enormous proliferative capacities and as the result 
MSCs are able to extend more than 10 passages in vitro 
without losing their original characteristics.50-52 Previous 
studies show that the proliferation and differentiation 
of stem cells  are  due  to  the  influence of free radicals. 
Another study show that antioxidants obtained from herbal 
extracts also play role in differentiation and proliferation of 
MSCs.53
 MSCs population could be found in every organ and 
tissue in the body such as umbilical cord, umbilical cord 
blood, peripheral blood, adult connective tissue, placenta, 
amniotic membrane, dental tissue and bone marrow.11 
Recently, the use of human ASCs from bone marrow was 
widely explored for cell and gene therapy purposes. In 
specific culture condition, BM-MSCs have the ability to 
differentiate into several cell lineages including osteoblasts, 
adipocytes, chondrocytes, myoblasts and early progenitors 
of neural cells, comparable to PDLSC.54 Another example 
is MSCs found from lipoaspirate, a waste product from 
liposuction procedure. The MSCs from lipoaspirate is often 
called adipose-derived stem cells.55  
 In order to ensure the future use of MSCs, MSCs 
derived from tissues need to be preserved. Cyropreservation 
is one of the most important steps to ensure the future use of 
stem cells. Slow-cooling method of cryopreservation is the 
most frequently used to preserve various cells, tissues and 
organs. In addition to slow-cooling method, the previous 
research has shown that rapid-cooling method is a potential 
cryopreservation method.56 
Identification of MSCs
Interest and research about MSCs have risen over the last 
two decades. A lot of investigation have been conducted and 
many laboratories develop methods to isolate and expand 
MSCs. However, the defining characteristics of MSCs are 
still inconsistent which lead to an inability of comparing 
and contrasting studies. Thus, the ISCT proposed three 
criteria in defining MSCs which are adherence to plastic, 
specific surface antigen (Ag) expression and multipotent 
differentiation potential.49
Plastic adherence
Plastic adherence is a well-described property of MSC 
and unique subsets of MSCs.49 MSCs are often isolated 
by adherence selection in which the MSCs are placed in 
plastic tissue culture vessels and maintained under standard 
conditions. The nonadherent cells, such as hematopoietic 
cells, are removed while the remaining adherent cells are 
MSCs.57
Specific surface antigen (Ag) expression
Surface antigen has been used for identification of a cell 
population. It has been shown that more than 95% of MSCs 
expressed CD105, CD73 and CD90, while less than 2% of 
MSCs expressed hematopoietic Ag. Thus, ISCT proposed 
that MSCs must express CD105, CD73 and CD90, and lack 
in expressing the hematopoietic Ag. Some of the examples 
of hematopoietic Ag are CD45, CD34, CD14 or CD11b, 
CD79 or CD19 and HLA-DR.
 CD105 is originally recognized by the Mab SH2 and 
known as endoglin.49 CD105 is a membrane glycoprotein 
and plays an important role in angiogenesis.58 CD105 is 
also a component of the receptor complex of transforming 
growth factor- beta (TGF-β) involved in cell proliferation, 
differentiation, migration and interactions between MSCs 
and hematopoietic cells.59,60 Studies also found that CD105+ 
MSCs are capable of differentiating into adipogenic, 
osteogenic and chondrogenic lineages.59,61 Besides 
CD105, MSCs should also express CD73, known as ecto 
5’nucleotidase (originally recognized by the Mab SH3 and 
SH4) and CD90, known as Thy-1.49 CD90 is a cell surface 
anchored glycoprotein that is expressed on MSCs and have 
a role in cell motility as well in cell-cell and cell-matrix 
interactions.50, 62
 Several studies have shown that dental MSCs showed 
other cell surface antigen than CD105, CD73 and CD190 
(Table 1). For instance, DPSC showed positive markers of 
CD146, STRO-1, CD106, CD29, CD51, CD61, CD166, 
ALDH1, 3G5, CD44, CD9, CD10, CD13, CD59, MSCA-
1, CD81, CD24 and several others.29,32,35 A possible reason 
for differential expression of antigens of DPSC may be the 
presence of different subpopulations of MSCs in dental pulp 
which has different biological activities. For example, a high 
proliferative DPSC showed the positive marker of CD44, 
CD90 and CD166, while DPSC with odonto-osteogenic 
properties expressed STRO-1. Another example is DPSC 
that has higher capacity of self-renewal and osteogenic 
differentiation, express CD34 and CD117.2,3 
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Multipotent differentiation potential
Stem cells are categorized by their potential to differentiate 
into other types of cells which are totipotent, pluripotent, 
multipotent and unipotent. Multipotent stem cells have the 
ability differentiate into all cell types within one particular 
lineage and self-renewing.63 Although multipotent stem cells 
can produce other lines of cells, it is limited in its capacity 
of differentiation. Various research has established that this 
specific stem cell can differentiate into different tissue such 
as bone, muscle, cartilage, fat and other related tissues.64
 MSCs seem to have the potency which surpassed the 
formerly supposed restrictions for generating different cell 
types. This potential result of plasticity can be applied in 
stem cell therapy. It means that if researchers can arrange 
this differentiation, for example, a blood stem cell could be 
applied as a substitute for other tissues. Multipotent Stem 
cells have been applied in treatment of different disorders 
such as spinal cord injury, bone fracture, autoimmune 
diseases, rheumatoid arthritis, hematopoietic defects and 
fertility preservation.65
 Multipotent MSCs has the capability of self-renewing 
and differentiating into various cell lineages.66 Therefore, 
MSCs are promising cells for tissue engineering. MSCs 
are key to regenerative wound healing. MSCs orchestrate 
wound repair by structural repair via cellular differentiation, 
immune-modulation, secretion of growth factors that drive 
neovascularization, re-epithelialization and mobilization of 
resident stem cells.67 Not only that, MSCs have significant 
clinical implications in immunosuppressive and anti-
inflammatory effects through the interactions between the 
lymphocytes associated with both the innate and adaptive 
immune systems. MSCs suppress T cell proliferation, B 
cell functions, natural killer cell proliferation and cytokine 
production. It also prevent the differentiation, maturation, 
and activation of dendritic cell.
Conclusion
MSCs are ASCs that could be found in our body tissues 
such as dental tissues. Dental MSCs are described as 
non-hematopoietic stromal cells with the capability to 
differentiate into many different cells in the body and 
serve to develop, repair and regenerate the mesenchymal 
tissues. There are several types of dental MSCs depending 
on the tissue origin, such as DPSC, SCAP, SHED, which 
have difference in membrane biomarkers and the ability to 
differentiate, repair and regenerate.
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